Search Results for: immunotherapy
FDA Drops New Oncology Development Guidelines
2022-10-18
Kite’s Yescarta Climbs Up To Treat Second-Line B-Cell Lymphomas After EC Nod
2022-10-18
ImmVira announced to launch the construction of Global R&D and Commercialization Base
2022-10-18
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
Illumina Genomics Forum Kicks Off With A Conversation With President Barack Obama
2022-09-29
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop “Off-the-Shelf” CAR-iMAC Cell Therapy
2022-09-26
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15
Data from KN046 in Patients with metastatic NSCLC who failed first line treatment or prior EGFR-TKIs Presented at ESMO 2022
2022-09-13
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line(1L)treatment for NSCLC at ESMO 2022
2022-09-13
Lactate’s Potential is an Immunotherapy Supplement for Cancer Treatments
2022-09-12
ESMO 2022 – Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
2022-09-09
1 3 4 5 6 7 24
Scroll to Top